Abstract
Glycosaminoglycans (GAG) are most commonly isolated as large polymers from various animal origins, the functional units of which are oligosaccharides, which bind their target proteins to induce conformational changes, compete with other ligands, or facilitate the formation of signaling complexes. One example, the extensively studied heparin pentasaccharide sequence—which binds antithrombin-III, inducing a conformational change that increases its serpin protease activity by 1,000-fold—is unique in that no other specific GAG-protein structure-function relations have been described to the same degree. Thus, production of heparan sulfate (HS) oligosaccharides is critical for obtaining specific structural information regarding the binding interactions of GAG and their ligands (typically proteins). Purely synthetic methods of oligosaccharide synthesis are possible, but the cost, time requirement, and difficulty of their preparation prohibit library synthesis in significant amounts. Herein, the use of bacterial heparin lyases for the production of HS oligosaccharides via enzymatic depolymerization of HS polymers is discussed. The separation and purification of these oligosaccharides by liquid chromatography are also described.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Esko JD, Kimata K, Lindahl U (2009) Proteoglycans and sulfated glycosaminoglycans. In: Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME (eds) Essentials of glycobiology, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp 229–248
Casu B, Lindahl U (2001) Structure and biological interactions of heparin and heparan sulfate. Adv Carbohydr Chem Biochem 57:159–206
Capila I, Linhardt RJ (2002) Heparin-protein interactions. Angew Chem Int Ed Engl 41(3):391–412
Conrad HE (2001) Nitrous acid degradation of glycosaminoglycans. Curr Protoc Mol Biol. Chapter 17:Unit17.22A
Hovingh P, Linker A (1970) The enzymatic degradation of heparin and heparitin sulfate. 3. Purification of a heparitinase and a heparinase from flavobacteria. J Biol Chem 245(22):6170–6175
Pervin A, Gallo C, Jandik KA, Han XJ, Linhardt RJ (1995) Preparation and structural characterization of large heparin-derived oligosaccharides. Glycobiology 5(1):83–95
Babu P, Kuberan B (2010) Fluorescent-tagged heparan sulfate precursor oligosaccharides to probe the enzymatic action of heparitinase I. Anal Biochem 396(1):124–132
Rusnati M, Oreste P, Zoppetti G, Presta M (2005) Biotechnological engineering of heparin/heparan sulphate: a novel area of multi-target drug discovery. Curr Pharm Des 11(19):2489–2499
Linhardt RJ, Galliher PM, Cooney CL (1986) Polysaccharide lyases. Appl Biochem Biotechnol 12(2):135–176
Jones CJ, Beni S, Limtiaco JF, Langeslay DJ, Larive CK (2011) Heparin characterization: challenges and solutions. Annu Rev Anal Chem 4:439–465
Acknowledgement
This work was supported in part by NIH grants (P01HL107152 and R01GM075168) to B.K. and by the Eccles fellowship to S.B.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Brown, S., Kuberan, B. (2015). Production of Size-Defined Heparosan, Heparan Sulfate, and Heparin Oligosaccharides by Enzymatic Depolymerization. In: Balagurunathan, K., Nakato, H., Desai, U. (eds) Glycosaminoglycans. Methods in Molecular Biology, vol 1229. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1714-3_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1714-3_3
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1713-6
Online ISBN: 978-1-4939-1714-3
eBook Packages: Springer Protocols